Clinical Trial Update: Potential Role of Guselkumab in Modulating PAIN Perception and Related Gene Pathways: a Proof-of-concept Study. [Phase 4]

View source ↗

Summary

Phase 4 proof-of-concept study evaluating whether guselkumab can modulate pain perception and related gene pathways in psoriatic arthritis; currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriatic Arthritis

Drugs mentioned

• TREMFYA (guselkumab)

Snippet

Sponsor: Fondazione Policlinico Universitario Campus Bio-Medico | Conditions: Psoriasis Arthritis | Phase 4 | Status: RECRUITING